What the evidence shows
Myo-inositol (2-4g/day) combined with D-chiro-inositol in a 40:1 ratio improves insulin sensitivity, ovulation rates, and cycle regularity in women with PMOS. The 2023 international PMOS guidelines note inositol as a supportive intervention alongside medical care.
What Is Inositol?
Inositol is a naturally occurring compound your body produces. It plays a key role in insulin signaling — specifically in how your cells respond to insulin. This matters enormously for PMOS, because insulin resistance is at the root of the condition in 50-70% of affected women. When insulin signaling improves, androgen levels drop, follicles develop more normally, and ovulation becomes more likely.
There are two main forms that matter for fertility:
- Myo-inositol (MI) — the most abundant form in the body. Plays a central role in FSH (follicle-stimulating hormone) signaling and insulin sensitivity. Most fertility research uses this form.
- D-chiro-inositol (DCI) — involved in insulin-mediated glycogen synthesis and androgen metabolism. Important but in much smaller quantities. Over-supplementation of DCI alone has been associated with impaired egg quality.
The 40:1 Ratio
This is the critical detail most products get wrong. The physiological ratio of myo-inositol to D-chiro-inositol in human follicular fluid is approximately 40:1. Research shows this ratio produces the best outcomes for PMOS fertility — improving both insulin sensitivity and ovulatory function without the egg quality concerns associated with high DCI doses.
Products that contain only DCI, or that use a different ratio (like 1:1), don't match the evidence and may actually be counterproductive for egg quality.
What the Research Shows
- Ovulation: Meta-analyses show myo-inositol improves ovulation rates by 40-70% in women with PMOS compared to placebo
- Insulin sensitivity: A 2017 meta-analysis of RCTs found significant reductions in fasting insulin and HOMA-IR (a measure of insulin resistance)
- Testosterone: One trial showed total testosterone dropped from 99.5 ng/dL to 34.8 ng/dL with myo-inositol supplementation
- Cycle regularity: Multiple studies report improved cycle regularity within 2-3 months of consistent supplementation
- IVF outcomes: When used alongside fertility treatment, inositol has been shown to improve oocyte quality and reduce the amount of gonadotropins needed during stimulation
The 2023 international PMOS guidelines note that inositol should not be used as a standalone fertility treatment — but it can support metabolic and ovulatory function alongside medical care. Think of it as a foundation, not a replacement for letrozole or other ovulation induction if needed.
Dosing
- Myo-inositol: 2,000-4,000 mg per day (most studies use 4,000 mg)
- D-chiro-inositol: 50-100 mg per day (to maintain the 40:1 ratio)
- Timing: Split into 2 doses (morning and evening) for better absorption
- How long: Allow 3 months for full effect (follicle development takes ~85 days)
- Side effects: Generally well-tolerated. Mild GI upset (nausea, bloating) possible at higher doses. Usually resolves with dose adjustment.
Our Product Picks
🏆 Best Overall: Ovasitol by Theralogix
The gold standard for PMOS inositol supplementation. Uses the evidence-based 40:1 ratio (2,000 mg MI + 50 mg DCI per packet). Powder format dissolves in water. NSF-certified. This is what most PMOS-focused dietitians and REs recommend. Two packets per day = the full 4,000 mg MI dose.
Best Capsule: Wholesome Story 40:1
If you prefer capsules over powder, Wholesome Story delivers the correct 40:1 ratio at a much lower price point. 2,000 mg MI + 50 mg DCI per serving. Third-party tested. You'll need 2 servings/day for the full clinical dose.
Budget Pick: Life Extension Myo-Inositol
Pure myo-inositol without DCI. Good option if you want to dose MI alone or pair it with a separate DCI supplement. Third-party tested. Extremely affordable — but you'll need to add DCI separately to get the 40:1 ratio.